Contact Us

Walter Strapps of Idera to speak at Nucleic Acid R & D Meeting, June 19&20, 2014, San Diego, CA.

Walter R. Strapps, Executive Director of RNA Therapeutics at Idera Pharmaceuticals, Inc., to give a presentation titled "Gene Silencing Oligos The Next Generation in Gene Silencing"
    SAN DIEGO, CA, April 02, 2014 /24-7PressRelease/ -- Walter R. Strapps, Executive Director of RNA Therapeutics at Idera Pharmaceuticals, Inc., to give a presentation titled "Gene Silencing Oligos: The Next Generation in Gene Silencing" at the Inaugural Nucleic Acid Research and Development Conference, June 29 & 20, 2014 in San Diego, CA.

Dr. Strapps leads the RNA Discovery unit at Idera and is responsible for research and development of Idera's gene silencing oligo (GSO) platform. Dr. Strapps joined Idera in 2014. Prior to Idera, Dr. Strapps was Director, RNAi Therapeutics at Merck & Co., Inc. where he led siRNA lead identification and lead optimization efforts. Dr. Strapps holds a B.Sc. in Biology from McGill University and an M.A., M.Phil and Ph.D. in Genetics and Development from Columbia University.

Dr. Strapps talk will discuss:

• A unique oligonucleotide platform with two linked single strands
• Structure mitigates concerns and improves upon antisense
• Investigation into SAR provides opportunities for further optimization

For more information, please visit http://www.gtcbio.com/nucleicacid/agenda

GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.

GTC (Global Technology Community), LLC, is a privately held company founded in 2002.


# # #

Read more Press Releases from Kristen Starkey:


Contact Information


Kristen Starkey
GTC

Monrovia, California
United States
Voice: 626-256-6405
E-Mail: Email Us Here
Website: Visit Our Website

Like This Story?


I like it! 0

Disclaimer


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.